Chitosan nanoparticles (CSNPs) are promising vehicles for targeted and controlled drug release. Recognized for their biodegradability, biocompatibility, low toxicity, and ease of production, CSNPs represent an effective approach to drug delivery. Encapsulating drugs within nanoparticles (NPs) provides numerous benefits compared to free drugs, such as increased bioavailability, minimized toxic side effects, improved delivery, and the incorporation of additional features like controlled release, imaging agents, targeted delivery, and combination therapies with multiple drugs. Keys parameters in nanomedicines are drug loading content and drug loading efficiency. Most current NP systems struggle with low drug loading, presenting a significant challenge to the field. This review summarizes recent research on developing CSNPs with high drug loading capacity, focusing on various synthesis strategies. It examines CSNP systems using different materials and drugs, providing details on their synthesis methods, drug loadings, encapsulation efficiencies, release profiles, stability, and applications in drug delivery. Additionally, the review discusses factors affecting drug loading, providing valuable guidelines for future CSNPs’ development.

Despite recent advances, cancer remains the primary killer on a global scale. Numerous forms of research have been conducted to discover novel and efficient anticancer medications. The complexity of breast cancer is a major challenge which is coupled with patient-to-patient variations and heterogeneity between cells within the tumor. Revolutionary drug delivery is expected to provide a solution to that challenge. Chitosan nanoparticles (CSNPs) have prospects as a revolutionary delivery system capable of enhancing anticancer drug activity and reducing negative impacts on normal cells. The use of smart drug delivery systems (SDDs) as delivering materials to improve the bioactivity of NPs and to understand the intricacies of breast cancer has garnered significant interest. There are many reviews about CSNPs that present various points of view, but they have not yet described a series in cancer therapy from cell uptake to cell death. With this description, we will provide a more complete picture for designing preparations for SDDs. This review describes CSNPs as SDDSs, enhancing cancer therapy targeting and stimulus response using their anticancer mechanism. Multimodal chitosan SDDs as targeting and stimulus response medication delivery will improve therapeutic results.

The deposition of monosodium urate (MSU) crystals within joint spaces produces a painful inflammatory condition known as gout, a specific form of arthritis. The condition calls for a combined curative and preventive management model. A new development in the approach to gout is that of NLRP3-targeted biologic agents, such as monoclonal therapies, to provide more accurate treatment by blocking specific pro-inflammatory cytokines. Nanoparticle drug delivery enhances biological availability and delivery to targets, which may increase therapeutic efficacy and decrease general toxicity. The preventive approach again cannot be ignored, mainly keeping up certain modifications in diet and weight, along with pharmacological therapies to reduce uric acid (UA) levels and to decrease the frequency of acute attacks. The advancement of genetic profiling of patients and biomarker discoveries drives the trend towards building individualized medicine and care, quickly gaining ground as the most effective method of delivering treatments to individual patients, moving away from one-size-fits-all treatments. The following paper aims to provide an updated account of the management of gout with a focus on recent developments, in order to enhance these approaches, the quality of life for patients with gout, and the standard of gout treatment.

Reactive oxygen species (ROS), commonly known as free radicals, induced by UV radiation can compromise the dermal structure, leading to a loss of skin elasticity and subsequent wrinkle formation. A promising strategy to prevent and mitigate skin aging involves the use of topical formulations with potent antioxidant properties. Secondary metabolites such as astaxanthin and zeaxanthin are known for their robust antioxidant activities, which surpass those of tocopherol, offering significant benefits for skin health and protection against UV-induced damage. These properties suggest their potential application in anti-aging products. This study aims to evaluate the stability, ex vivo penetration, and in vivo efficacy of a radiance serum containing an astaxanthin–zeaxanthin nanoemulsion (AZ-NE) designed as an anti-wrinkle agent for topical application. The research was conducted in four stages: production of the astaxanthin–zeaxanthin nanoemulsion (AZ-NE), formulation of the AZ-NE radiance serum, stability, and efficacy testing. In this study, the formulated radiance serum demonstrated stability over three months under specified storage conditions. Ex vivo penetration studies indicated efficient diffusion of the active ingredients, with astaxanthin showing a penetration rate of 25.95%/cm² and zeaxanthin at 20.80%/cm² after 120 min. In vivo irritation tests conducted on human subjects revealed no adverse effects. Moreover, the serum exhibited substantial anti-wrinkle efficacy, with 15 female participants experiencing a wrinkle reduction of 80% to 93% over a 28-day period.

This review article aimed to study chitosan as a material based in wound dressing preparation. The method in this review is the approximation method. The articles were obtained from national and international journals such as Scopus, PubMed, and Google Scholar by using the keywords "Chitosan", "Wound Healing", and "Biomedical Application". The inclusion criteria of the article are: national and international journals and books contains chitosan as, published in the last ten years, and not review article. The final articles used in this review are 29 articles that studying the use of chitosan as wound dressing material. The combination of chitosan with some polymer, ion and other materials resulting the chitosan-based materials namely nanofibrous membranes, composites sponge, polyelectrolyte complex, and composites, that used in topical preparation such as membranes, fibers, sponge, film, and gel. Thus, the modified of chitosan wound healing preparation resulting in the improve of healing activity of each preparation from. This review summarizes chitosan application in wound healing. Several studies were proposed the porous structure of chitosan-based materials lead the improvement of healing activity.